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The Effects of Tocotrienol Supplementation on Exercise-Induced 
Lipid Peroxidation and Endurance Performance in the Heat 
ABSTRACT 
INTRODUCTION: The increase in oxygen consumption during endurance 
exercise leads to free radical (FR) production and subsequent lipid peroxidation (LIPOX). 
Raised body temperature has also been reported to increase the rate of FR production. 
This oxidative stress may impair endurance performance since FRs can cause cell 
damage and has been implicated in muscular fatigue. Vitamin E supplementation has 
been shown to attenuate FR-induced LIPOX. It is however unclear if vitamin E 
supplementation could decrease LIPOX and improve endurance running performance of 
heat-adapted recreational athletes in the heat. PURPOSE: This study examined the 
effects of tocotrienol (Palm Vitee) supplementation on exercise-induced LIPOX and 
endurance performance in the heat. METHODS: 18 healthy, male recreational athletes 
(aged: 24.9 ± 1.4 yrs; body weight: 59.6 ± 1.5 kg; V02max: 57.7 ± 1.5 ml.kg·1.min"1) 
completed two endurance running trials until exhaustion on a motorised treadmill at 70°/o 
V02max on two separate occasions following a 6-week supplementation of either vitamin E 
(E) or placebo (P). Both trials were conducted at an ambient temperature of 31°C and a 
70°/o RH. During the trials, rectal temperature (T rec), skin temperature (Tsk). heart rate 
(HR) and ratings of perceived exertion (RPE) were recorded at 1 0-min intervals while 
oxygen uptake (V02) was recorded every 20 min. Blood samples were collected every 
20 min during the running trials for the determination of plasma volume changes (PVC), 
lactate (LAC), glucose (GLU), free fatty acid (FFA), triglyceride (TRI), malondialdehyde 
(MDA), creatine kinase (CK), total antioxidant status (TAS) and vitamin E. RESULTS: No 
significant differences were evident in T rec• T Skt HR. RPE, vo2 or in the time to exhaustion 
between the E and P trials (81.1 ± 4.5 vs 76.9 ± 4.5 min respectively). Similarly, PVC, 
CK, LAC, GLU, FFA, TRI and TAS were also not different between the two trials. Vitamin 
E supplementation, however, resulted in a significantly higher (p<0.001) mean serum 
vitamin E concentration at rest and during post-exercise compared to that in the placebo 
1 
tnal. Resting plasma MDA concentration in the E trial was significantly lower than that in 
the P trial (0.38 vs 0.46 pmol.l"1; p<0.05). At exhaustion. plasma MDA was higher than 
the resting values in both trials and it was higher in the P trial compared to the E trial 
although the difference did not reach statistical significance (p=0.090). CK activity at 
exhaustion, 1 h and 24 h post-exercise was not different during the two trials but was 
significantly higher {p<0.001) than the corresponding resting values in both trials. 
CONCLUSION: Vitamin E supplementation decreased lipid peroxidation at rest and, to 
some extent, during exercise in the heat as evident from the lower MDA levels. It 
however, does not enhance endurance running performance or prevent exercise-induced 
muscle damage during exercise in the heat. In addition, vitamin E supplementation did 
not influence the changes of some of the physiological parameters (e.g. PVC, LAC, GLU, 
FFA, TRI, CK and TAS) that occurred during exercise in the heat. 
Key W!Jrds: Endurance running performance, lipid peroxidation, muscle damage, 
heat, vitamin E 
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1. INTRODUCTION 
During exercise. oxygen uptake can be elevated 1 0 - 20 times to meet the 
increased metabolic demand of the exercising muscles (Astrand & Rodahl, 1986). Under 
normal circumstances, a small amount of univalently produced oxygen intermediates, 
termed free radicals, leak out of the electron transport chain during this process (Chance 
et a/.. 1979) and results in the production of free radicals like superoxide, peroxyl and 
hydroxyl radicals (Chance et a/., 1979; Jenkins, 1988; Holley & Cheeseman, 1993; 
Gutteridge & Halliwell, 1994; Sen 1995). Free radicals are unstable molecules or 
fragments of molecules with unpaired electrons in their outer orbits (Sjodin et a/., 1990; 
Clarkson & Thompson, 2000; Powers eta/., 2004). They strive to balance their unpaired 
electrons by combining with electrons with opposite spins in other molecules that are 
important for cellular function (Sjodin eta/., 1990). By being unstable, free radicals are 
also highly reactive and can cause damage in the cells and tissues by initiating chemical 
chain reaction like lipid peroxidation (Jenkins, 1988; Duthie, 1993; Gutteridge & Halliwell, 
1994; Packer, 1997). Membrane lipid peroxidation may alter fluidity and permeability of 
the membrane and thus compromise the integrity of the membrane barrier resulting in a 
loss of cellular function (Sen, 1995; Tiidus & Houston, 1995; Dekkers et a/., 1996; Evans, 
2000; Powers eta/., 2004) and even cell death (Hollan, 1996). 
Reactive oxygen species (ROS) represent a broad spectrum of species, including 
non-radical derivatives of oxygen (hydrogen peroxide, singlet oxygen, hydroperoxides) 
that are also capable of inciting oxidative tissue damage (Sen, 1995). Most cells in the 
body, including skeletal muscle cells, contain several naturally occurring mechanisms for 
the protection against injuries caused by ROS (Laughlin et a/., 1990). The ROS are 
neutralised by an elaborate antioxidant system comprising of enzymes such as 
superoxide dismutase, catalase, glutathione peroxidase and non-enzymatic antioxidants 
such as vitamins A, E and C, glutathione, ubiquinone, a-lipoic acid and flavonoids (Gohil 
3 
et a/., 1988; Kanter, 1998a; Kanter 1998b; Criswell et a/., 1993; Goldfarb. 1993; Ursa & 
Clarkson, 2003. Powers et a/., 2004 ). Therefore, these enzymatic and non-enzymatic 
antioxidant defence systems protect the membranes and other cell organelles from the 
damaging effects of free radical reactions (Gohil et a/., 1988; Goldfarb, 1993; Yu, 1994; 
Kanter, 1998a; Kanter 1998b; Goldfarb, 1999; Evans, 2000; Powers et a/., 2004 ). 
During increased oxygen utilisation, as happens during exercise, the rate of 
production of these free radical species may exceed the body's capacity to detoxify them 
(Sjodin et a/., 1990). This can lead to increased oxidative stress and subsequent lipid 
peroxidation and cell damage (Davies eta/., 1982; Jenkins, 1988; Kanter eta/., 1988; 
Alessio, 1993; Goldfarb, 1993; Kanter, 1994; Sen, 1995; Tiidus & Houston, 1995; 
Dekkers eta/., 1996; Leaf eta/., 1997; Packer, 1997; Alessio eta/., 1998; Zoppi eta/., 
1998; Evans, 2000; Mastaloudis et a/., 2001 ). Free radical production reaches the 
highest.level when the exercise is exhaustive (Sastre eta/., 1992; Ji eta/., 1998, Li eta/., 
1998). Several studies have investigated the formation of free radicals during exercise 
and its relation to exercise-induced muscle damage (Clarkson & Tremblay, 1988; Kanter 
eta/., 1988; Barclay & Hansel, 1991; Vina eta/., 2000). 
Under normal circumstances, increased oxidative stress induced by exercise is 
equally matched by concomitant increase in antioxidant activity (Salminen & Vihko, 1983; 
Alessio & Goldfarb, 1988; Ji, 1993; Dekkers eta/., 1996; Powers eta/., 1999; Evans, 
2000). However, there is evidence to suggest that the antioxidant activity is not always 
adequate in preventing exercise-induced lipid peroxidation (lnal et a/., 2001; Ursa & 
Clarkson, 2003) and damage to cell membranes (Alessio, 1993; Jenkins & Goldfarb 
' 
1993; Sen, 1995; Takanami et a/., 2000). The oxidative stress that results from the 
deficiency of antioxidant nutrients has been shown to increase cell damage and reduce 
endurance capacity during strenuous physical activity in animal studies (Davies et a/., 
1982; Gohil eta/., 1986; Packer eta/., 1994 ). 
4 
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One of the nutrients that have shown promise as a protective antioxidant against 
free radical induced stress is vitamin E (Dillard et a/., 1978; Simon-Schnass & Pabst. 
1988; Sumida et a/., 1989; Cannon et al .. 1990; Meydani et a/., 1993; Rokitzki et al .. 
1994a; ltoh eta/., 2000; Schroder et a/., 2000; Jessup et a/., 2003). Vitamin E is the 
generic name describing bioactivities of both a-tocopherol and tocotrienol derivatives 
(Kayden & Traber, 1993; Kamal-Eldin & Appelqvist, 1996; Brigelius-Fiohe & Traber, 1999; 
Theriault et a/., 1999). Vitamin E reportedly reduces exercise-induced increase in lipid 
peroxidation (Dillard et a/., 1978; Simon-Schnass & Pabst, 1988; Sumida et a/., 1989; 
Rokitzki et a/., 1994a; Evans, 2000). Furthermore, vitamin E supplementation has also 
been shown to reduce the leakage of creatine kinase, a marker of exercise-induced 
muscle damage following exhaustive cycle exercise (Rokitzki et a/., 1994a) and 
endurance running (ltoh, eta/., 2000). 
Despite the ability of vitamin E to reduce free radical induced cell damage during 
exercise, its role in enhancing endurance performance remains debatable. High pre-race 
plasma vitamin E level has been associated with enhanced physical endurance in dogs 
(Piercy et a/., 2001 ). Another study showed that running time to exhaustion was reduced 
by approximately 30-40°/o for untrained rats fed with a vitamin E-free diet (Gohil et a/., 
1986). Most human studies, however, have failed to demonstrate any performance 
enhancement associated with vitamin E supplementation (Sharman et a/., 1971; 
Shephard eta/., 1974; Lawrence eta/., 1975; Rokitzki eta/., 1994b; Nielsen eta/., 1999) 
except when exercise was performed at high altitude (Simon-Schnass & Pabst, 1988). 
Interestingly, however, little has been studied on free radical activities during exercise in 
the heat and the influence of vitamin E supplementation on free radical activities and 
performance in the heat. 
Elevated body temperature has been shown to increase the rate of free radical 
production (Kanter, 1994; Dekkers eta/., 1996; Clanton eta/., 1999; DiMeo & Venditti, 
5 
2001: Altan eta/., 2003) and there is growing evidence that free radical production during 
exercise contributes to muscular fatigue (Novelli et a/.. 1990; Shin doh et a/.. 1990; 
Barclay & Hansel, 1991; Reid et a/., 1992; O'Neill et a/., 1996). 
To our knowledge, to date no scientific studies have examined free radical activity 
during exercise in a hot and humid environment, particularly in heat-adapted recreational 
athletes. Furthermore, most studies investigating the effect of vitamin E on performance 
have used tocopherol and none have used combined a-tocopherol and tocotrienol 
supplements. The present study therefore investigates the effects of Palm Vitee 
(tocotrienol-rich fractions) supplementation on exercise-induced lipid peroxidation and 
endurance performance in the heat of heat-adapted recreational athletes. 
2. METHODS 
2.1 SUBJECTS 
Twenty-five male recreational athletes were recruited as subjects in this double-
blind, placebo-controlled. randomised cross-over study (Fig. 2. 1 ). Participation in regular 
physical activity of the subjects was determined through a biodata form (Appendix A). 
The experimental protocols were explained to them, in addition to what was required of 
them before they were asked to sign a consent form (Appendix B). The study protocol 
was approved by the Research and Ethics Committee of Universiti Sains Malaysia 
(Appendix C). 
6 
•, 
I 
Recreational athletes 
n = 18 
Preliminary trials to esta lish maximal oxygen uptake and 
the relationship between running speed and oxygen uptake 
l 
Endurance running practice without prior supplementation 
in the Heat (31°C) 
I 
~ 
Double blind, Placebo-controlled, 
Randomised Crossover trial 
l 
Supplementation with either Palm Vitee or Placebo for 6 weeks 
4_ 
I Endurance Running Performance in the Heat (31°C) I 
1 
Washout Period (2 weeks) I 
.. 
Supplementation with. either Palm Vitee or Placebo for 6 weeks 
Endurance Running Performance in the Heat (31 °C) 
Supplementation. with Palm Vitee 
- Running· Performance.->. 
Supplementation with Placebo 
- Running Performance 
- Index of lipid peroxidation 
- Physiological parameters 
- Index of.Jipid peroxidlili()n~ · · · · 
- Physiological parameters' 
Figure 2.1. Experimental design of the study. 
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2.2 TEST PROCEDURES 
2.2.1 Preliminary Measurements 
The subjects' body weight and percent of body fat were obtained by using an 
electronic body composition analyzer (Tanita® TBF-41 0, Japan). A telescoping 
measuring rod {Seca 220, Germany) was used to measure the height of the subjects. 
After familiarisation with treadmill running, the subjects performed two tests: 
i) A 16-min incremental sub-maximal running test to determine the relationship between 
running speed and oxygen uptake. 
ii) An uphill incremental treadmill-running test to determine maximum oxygen uptake 
(V02max). 
For the sub-maximal test, the subjects were fitted with a heart rate sensor (Sport 
Tester PE3000, Polar, Finland), a mouthpiece and a nose clip. A head gear was fitted to 
support a two-way non-re-breathing valve (Hans Rudolph 2700 series, USA) attached to 
the mouthpiece. The subjects then ran on a motorised treadmill {Quinton 18-60, USA) for 
four minutes at four different speeds {7, 8, 9 and 10 km.h-1) over a period of 16 minutes. 
All expired air during the tests was passed through a mixing chamber where sensors to 
the pre-calibrated paramagnetic oxygen and infrared carbon dioxide analysers 
{SensorMedics 2900, USA) were used to determine the percentages of oxygen and 
carbon dioxide respectively in the expired air. Both analysers were calibrated using two 
nitrogen-based calibration gases {26°/o oxygen in nitrogen mixture, and 4°/o carbon 
dioxide and 16°/o oxygen in nitrogen mixture)_. The output from the gas analysers was 
processed using a computer for the calculation of oxygen consumption (V02) and carbon 
dioxide production {VC02). On the· average, these measurements were recorded every 
8 
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20 seconds. V02 values in ml.kg·1.min· 1 were the averages of the highest values 
measured during the final 60 seconds of each measurement. 
Maximum oxygen uptake was determined using a modified Astrand protocol 
(Heyward, 1991 ). This test required the subjects to run to volitional exhaustion during a 
continuous incremental run on a motorised treadmill. Subjects were initially allowed to 
warm-up for -5 minutes at a low speed (6-7 km.h-1). After the warm-up, the subjects 
were fitted with the headgear, mouthpiece, nose-clip and heart rate sensor as in the sub-
maximal test. An appropriate speed (8-12 km.h-1) was selected and the test began with a 
grade of 0°/o for 3 minutes. Thereafter, the grade was increased 2 1/2o/o every 2 minutes 
and the subjects were encouraged to run until exhaustion. Expired air samples and heart 
rate responses were measured at the end of each 2-minute stage. The V02max value was 
accepted to have been reached when there was a plateau in oxygen uptake despite 
increasing workload (American College of Sports Medicine, 2000). Other criteria used to 
indicate the attainment of V02max were: 
i) Failure of heart rate to increase with increases in exercise intensity. 
ii) A respiratory exchange ratio of >1.15 (American College of Sports Medicine, 
2000). 
From on the data obtained, running speeds during warm-up (50°/o V02max) and 
during endurance running performance (70o/o V02max) were established from a regression 
equation with speed and oxygen uptake. After these preliminary tests, all the subjects 
were required to come and train on the motorised treadmill in the laboratory over a two to 
three week period before they were put on the first supplementation regimen. This was 
done to familiarise the subjects with the experimental protocol and to eliminate any 
possible 'learning effect' during the actual experimental trials. Five of the subjects 
dropped out for various reasons and twenty were put on the supplementation regimen. 
Two of the subjects withdrew from the study after the first supplementation period. The 
9 
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final data analysis for the second phase was derived from eighteen subjects who 
completed both the trials . 
2.2.2 Experimental Trials 
The randomised trials were conducted in an improvised climatic chamber where 
halogen lamps (Philips- 500W, France) were used to raise the ambient temperature to 
-31 °C in both the trials. Relative humidity in both the trials was maintained at 70°/o by 
using a heated water-bath (Memmert W350t, Germany) placed within the chamber. 
To minimise differences in resting muscle glycogen concentrations, subjects 
recorded their food intake for 3 d.ays before the first experimental trial in a food diary. 
They were then instructed to follow the same diet before the second trial. They were also 
required to refrain from training the day before each trial and to observe a 10-12 h fast 
before their arrival to the laboratory . 
Upon arrival at the laboratory, a standardised breakfast consisting of a slice of 
white bread (Gardenia®, Malaysia) and a glass of water (300 ml) was given approximately 
half an hour before the experimental trial. The subjects then emptied their urinary 
bladder. Nude body weight of the subjects was recorded using an electronic body 
composition analyzer (Tanita® TBF-410, Japan). Following this, a rectal thermistor 
(Yellow Springs Instrument, USA) was inserted to a depth of 10 em beyond the anal 
sphincter for the measurement of core temperature. In addition, skin thermistors (Yellow 
Springs Instrument, USA) were attached to the chest, biceps, thigh and calf for the 
measurement of mean skin temperature (Ramanathan, 1964 ). Core and skin 
temperatures were recorded on a temperature monitor (Libra Medical ET 300R, USA). 
The heart rate was monitored throughout the trial by a heart rate sensor (Sport Tester 
PE3000, Polar, Finland), which was fitted onto the chest wall. An indwelling cannula 
10 
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(Vasocan@:- 22 G. 1··. B. Braun, Malaysia) was inserted into a subcutaneous forearm vein 
and an extension tube (minimum volume extension tubing - 30 em, B. Braun. Malaysia) 
was connected to it to facilitate repeated blood withdrawals. Patency of the cannula was 
maintained with heparinised saline (10 IU heparin sodium in 1 ml 0.9°/o NaCI, B. Braun, 
Malaysia). Approximately O.Bml of heparinised saline was injected into the extension 
tube after each blood withdrawal. 
As the subject was being prepared, the environmental condition of the chamber 
was continuously monitored. Once the environmental temperature and relative humidity 
were stable, the subjects then moved into the chamber for the experimental trials. After 
standing on the treadmill for 5-10 minutes, a resting venous blood sample (8 ml) was 
collected and oxygen and carbon dioxide concentrations in the resting expired air sample 
were measured (Fig. 2.2). The subjects then had a warm-up run on the treadmill for 5 
minutes at 50°/o V02max. This was immediately followed by a run to exhaustion at exercise 
intensity of 70o/o V02max· Exhaustion was considered to have been reached when the 
subjects could no longer maintain the prescribed running speed . 
During each blood collection, the first 1 ml of the blood sample was withdrawn 
separately using a 5 ml sterile syringe {Becton Dickinson, Singapore). This amount was 
not included in the blood analysis as it was diluted by the heparinised saline. The syringe 
was then replaced, and 8 ml of blood was collected in a 1 0 ml sterile syringe (Becton 
Dickinson, Singapore). Blood samples were collected at the end of the warm-up period, 
at 20-minute intervals throughout the trials and at exhaustion while the subject was still 
on the treadmill. During the trials, oxygen and carbon dioxide concentrations in the 
expired air were recorded during the final mi~ute of the warm-up period, at 1 o minutes 
into exercise and every 20 minutes thereafter until exhaustion. After completion of the 
warm-up and at intervals of 20 minutes, 3 ml.kg-1 body weight of cooled water {4-8°C) 
11 
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was consumed by the subjects to avoid any possible adverse effects of dehydration (Fig. 
2.2) . 
Heart rate, ratings of perceived exertion (RPE), core and skin temperatures, room 
temperature and relative humidity were recorded at 1 0-minute intervals throughout the 
trials. Heart rate responses during the trials, which were recorded via the heart rate 
monitor, were later downloaded onto a desktop computer for analysis. RPE was obtained 
using the Borg's scale (Borg, 1998). Fluid sensation was obtained at 20-minute intervals 
(Fig. 2.2) using a fluid sensation scale (Peryam & Pilgrim, 1957). 
At the point of exhaustion, and to ensure that the subjects were truly fatigued, the 
running speed was reduced to elicit 60o/o V02max for 2 minutes. Thereafter, the speed 
was returned to the prescribed speed (70°/o V02max) and the subjects were further 
encouraged to run as long as possible (Chryssanthopoulos & Williams, 1997; Wee eta/., 
1999). Verbal encouragement was given to all subjects by the same researcher. All 
time-keeping devices were kept out of sight of the subjects during these trials. Once the 
subjects stopped running, they were allowed to cool down for about 2 minutes on the 
treadmill at a walking pace of 4-6 km.h-1• 
After the completion of the run, the heart rate sensor and all the thermistors were 
removed from the subjects. After towel drying themselves, post-exercise nude body 
weight was measured. The difference in nude body weight and the amount of fluid 
consumed were then used to determine the sweat rate (Murray, 1996). Subjects were 
then given 500 ml of water and they rested in the laboratory (-25°C, -70°/o RH) before 
another venous blood sample (8 ml) was c?llected at 1 hour post-exercise. All the 
subjects were required to report to the laboratory 24 hours post-exercise when a further 
venous blood sample (8 ml) was collected. Each subject repeated the same procedure 
tor the subsequent trial. 
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2.3 Blood Collection and Analyses 
.... During the experimental trials. approximately 8 ml of venous blood was withdrawn 
... 
during each sample collection. One ml of blood from each sample was transferred to an 
EDTA (Ethylenediamine tetra-acetic acid) tube and was used for the determination of 
haematocrit and haemoglobin concentration. Haematocrit was determined by 
microcentrifugation (Hettich-Haematokrit 20, Germany) at 13,000 RPM for 10 minutes 
and using a Microhaematocrit Reader (Hawksley, England) while haemoglobin 
concentration was analysed by the cyanmethaemoglobin method (Drabkin's reagent). 
Percent change in plasma volume was calculated using a formula of van Beaumont et a/. 
(1981 ). 
From the remainder of the blood sample (7 ml), a volume of 0.5 ml was 
transferred to a natrium flouride containing tube and the plasma was separated by 
centrifugation (1 0 minutes, 4,000 rpm, 4°C; Hettich-Rotina 46RS, Germany). The plasma 
was divided into equal portions and stored at -80°C (Heto Ultra Freeze 341 0, Denmark) 
for subsequent analysis of lactate and glucose. Plasma lactate was estimated using a 
lactate analyser (Yellow Springs Instrument 1500, USA). Plasma glucose was analysed 
using a commercial glucose kit (Randox, U. Kingdom) and the concentration determined 
by a spectrophotometer (Shimadzu CL-750 Micro-Flow, Japan). 
Another 2 ml of the blood sample was anticoagulated with EDT A and plasma was 
separated by centrifugation (10 minutes, 4000 rpm, 4°C; Hettich-Rotina 46RS, Germany). 
The plasma from this sample was divided into five equal portions and stored at -80°C for 
subsequent analysis of free fatty acids, mal~ndialdehyde, creatine kinase, triglyceride 
and cholesterol. Plasma malondialdehyde was determined as thiobarbituric acid reactive 
substances (TSARS) by using a high performance liquid chromatography (HPLC) 
technique {Nielsen et a/., 1997). Total free fatty acids was analysed by using 
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commercially available reagent kit (Wako, Japan) and their concentration was determined 
by using a spectrophotometer (Shimadzu CL-750 Micro-Flow, Japan). Plasma creatine 
kinase and triglyceride were also analysed using commercially available kits (Randox, U . 
Kingdom). Plasma creatine kinase was determined by using a chemistry analyser (AMES 
Quik-Lab, Germany) while plasma triglyceride was determined using a spectrophotometer 
(Shimadzu CL-750 Micro-Flow, Japan). 
The remainder of the blood sample (4.5 ml) was allowed to clot and then 
centrifuged for 10 minutes at 4,000 rpm and 4°C (Hettich-Rotina 46RS, Germany}. The 
supernatant was divided into two portions and stored at -80°C (Heto Ultra Freeze 3410, 
Denmark) for the analysis of serum vitamin E and total antioxidant status. Serum total 
antioxidant status was analysed calorimetrically (Hitachi Automatic Analyzer 912, 
Behringer Mannheim, Germany) using a reagent kit (Randox. U. Kingdom). Serum 
vitamin · E was determined after extraction with hexane by a HPLC technique modified 
from Wahlqvist eta/. (1992) . 
2.4 Statistical Analysis 
All data were examined for normality through the Kolmogorov-Smirnov test. 
Descriptive statistics were performed on all dependent variables. ANOVA for repeated 
measures was used to determine the differences in physiological-related parameters over 
time between trials. The dependent parameters include heart rate. oxygen uptake, 
percent change of plasma volume, haematocrit, haemoglobin, core and skin 
temperatures, plasma malondialdehyde, plas~a creatine kinase. plasma free fatty acid, 
plasma lactate, plasma glucose. plasma triglyceride, plasma cholesterol, serum total 
antioxidant status and serum vitamin E. 
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Homogenity of variance in the data was determined using Mauchly's test. For 
data that violated the assumed sphericity, Greenhouse-Geisser correction was used to 
adjust the significance levels of the test statistics. Bonferroni adjustment for multiple 
comparisons was used to locate the differences when repeated measures analysis of 
variance revealed a significant main effect of time. When appropriate, students' paired t-
test was used to compare the differences between trials at individual time points. Ratings 
of perceived exertion and fluid sensation scale were analysed using Wilcoxon Signed-
Rank test. 
The Statistical Package for Social Sciences (SPSS) Version 10.0 was used for the 
statistical analysis. The accepted level of significance was set at p<0.05. Results were 
reported as means± standard error (SE) . 
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3. RESULTS 
3.1 SUBJECTS 
The subjects' age, height, weight, and 0/o body fat together with maximum heart 
rates and V02max. obtained during an uphill incremental treadmill-running test to 
exhaustion are shown in Table 3.1. 
Table 3.1 Physical characteristics and physiological capacities of subjects. 
Height Weight 0/o Body Heart Ratemax V02max Age 
(yr) (em) (kg) Fat (beats. min"1} (ml.kg"1.min"1) 
24.9 ± 1.4 169.2 ± 1.2 59.6 ± 1.5 18.0 ± 0.9 193 ± 2 57.7±1.5 
Values are means ± SE 
3.2 ROOM TEMPERATURE-AND RELATIVE HUMIDITY 
The average room temperature and relative humidity in the vitamin E (E) and 
placebo (P) trials are presented in Table 3.2. Both room temperature and relative 
humidity were stable during both the trials. There were no significant differences in room 
temperature and relative humidity between E and P trials. 
Table 3.2 Room temperature and relative humidity in the vitamin E supplemented (E) and 
placebo (P} trials. 
Trials Vitamin E (E) Placebo (P) 
Room Temperature (°C) 30.9 ± 0.1 31.0 ± 0.1 
Relative Humidity (o/o) 70.1 ± 0.2 70.3 ± 0.3 
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3.3 SERUM VITAMIN E 
The composition of each Palm Vitee capsule was 53 mg vitamin E (-33 °/o alpha-
tocopherol and -67 °/o tocotrienols). Therefore, the actual supplementation taken by the 
subjects during the vitamin E supplementation regimen was 318 mg (6 capsules x 53 mg) 
of vitamin E (tocotrienol-rich fractions) per day for 6 weeks. 
From ANOVA with repeated measures. it was found that there was a significant 
main effect of supplementation (F= 62.03; df= 1, 17; p<0.001) and a significant main 
effect of time (F= 13.21; df= 4, 68; p<0.001) on serum vitamin E during the trials. There 
was also a significant interaction between supplementation and time on serum vitamin E 
concentrations during the trials (F= 20.12; df= 2.25, 38.20; p<0.001 ). 
Compared to pre-supplementation levels, serum vitamin E concentrations were 
significantly higher (p<0.001) in the E trial (Fig. 3.1) after six weeks of supplementation. 
In contrast, there were no significant differences in serum vitamin E following placebo 
supplementation in the P trial. Serum vitamin E concentrations at exhaustion were higher 
when compared to the resting values in both trials but it was only statistically significant 
(p<0.05) in the P trial. Mean 24 h post-exercise serum vitamin E concentration was lower 
than the corresponding resting levels in both the trials but the differences were not 
statistically significant. Nevertheless, the 24 h post-exercise serum vitamin E level was 
significantly (p<0.05) lower than the corresponding values at exhaustion and at 1 h post-
exercise in the E trial. After the supplementation regimen, serum vitamin E 
concentrations were significantly higher (p<0.001) in the E trial compared to the p trial 
during and after exercise. All differences ?alculated for serum vitamin E remained 
statistically significant after adjusting data for plasma volume changes. However, the 
statistical significance between exhaustion and resting value in the p trial was lost. 
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Figure 3.1 Serum vitamin E (mg.dl"1) during and after exercise in the vitamin E 
supplemented (E) and placebo (P) trials. 
***significantly different from corresponding values in P (p<0.001 ). 
•, ••• significantly different from corresponding pre-supplementation value (p<0.05 
and p<0.001, respectively). 
#significantly different from respective resting value (p<0.05). 
' significantly different from respective exhaustion and 1 h post-exercise values 
(p< 0.05) . 
SERUM TOTAL ANTIOXIDANT STATUS (TAS) 
ANOVA with repeated measures revealed no significant main effect of 
supplementation (F= 0.18; df= 1, 17; p=0.679) but a significant main effect of time (F= 
44.45; df= 4, 68; p<0.001) on serum TAS during the trials. There was also no significant 
interaction between supplementation and time on the level of serum T AS during the 
experimental trials (F= 0.97; df= 2.45, 41.66; p=0.402). 
Resting serum T AS was not signifi~antly different from pre-supplementation 
values in both the trials. However, serum TAS was significantly higher (p<0.001) at 
exhaustion and at 1 h post-exercise when compared to the corresponding resting levels 
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Figure 3.2 Serum total antioxidant status (mmol.r1) during and after 
exercise in the vitamin E supplemented (E) and placebo (P) trials. 
••• significantly different from respective resting values (p<0.001 ). 
". ### significantly different from corresponding 24h post-exercise values (p<0.05 
and p<0.001, respectively). 
in the both the trials (Fig. 3.2). Serum TAS at 24 h post-exercise was not different from 
corresponding resting values in both trials and it was higher in the E trial compared to the 
p trial although statistical significance (p=0.071) was not found. Serum TAS at 24 h post-
exercise was significantly (p<0.05) lower than at exhaustion in the E trial. Similarly, 
serum 24 h post-exercise level in the P trial was significantly (p<0.001) lower than levels 
at exhaustion and 1 h post-exercise. There were no significant differences in serum T AS 
during and after exercise between the E and P trials. After the data were adjusted for 
plasma volume changes, serum T AS value at 24 h post-exercise was significantly higher 
(p<0.05) than the corresponding resting value in the E trial. Other calculated differences 
in serum T AS remained statistically significant except the value between exhaustion and 
at 24 h post-exercise in the E trial. 
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3.5 OXYGEN UPTAKE (V02) 
ANOVA for repeated measures indicated that there was no significant main effect 
of supplementation (F= 0.24; df= 1, 17; p=0.633) but a significant main effect of time (F= 
987.79; df= 2.57, 43.60; p<0.001) on oxygen uptake during the experimental trials. There 
was no significant interaction between supplementation and time on oxygen uptake 
during the endurance running trials (F= 0.60; df= 1.92, 32.57; p=0.553). 
Separate ANOVA with repeated measures for each trial indicated that oxygen 
uptake increased over time from rest until exhaustion (p< 0.001) in both the trials (Fig. 
3.3). Mean oxygen consumption during exercise was similar during both the trials (40.1 ± 
0.4 ml.kg·1.min·1 and 40.6 ± 0.5 ml.kg·1.min"1 in the E and P trial respectively). These 
figures correspond to 70.1 ± 0.6°/o and 70.6 ± 0. 7°/o of V02max which was maintained 
during theE and P trials respectively. 
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Figure 3.3 Oxygen uptake (ml.kg·1.min-1) during exercise in the vitamin E 
supplemented (E) and placebo (P) trials. 
+++significantly different from respective resting values (p<0.001 ). 
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3.6 PLASMA MALONDIALDEHYDE (MDA) 
ANOVA for repeated revealed no significant main effect of supplementation (F= 
2.51; df= 1, 17; p=0.132) but a significant main effect of time (F= 4.1 0; df= 4, 68; p<0.01) 
on the levels of plasma MDA during the trials. However, there was no interaction 
between supplementation and time on plasma MDA levels during the endurance running 
performance trials (F= 1.77; df= 4, 68; p=0.144}. 
Separate ANOVA with repeated measures for each trial indicated that there was 
an increase in the levels of MDA at exhaustion compared to the resting values in both 
trials but it was only statistically significant {p<0.001) in the E trial (Fig. 3.4 ). Post-
exercise MDA levels at 1 h and 24 h post-exercise were not significantly different when 
compared to the corresponding resting levels in both trials. Using paired t-tests, it was 
found that the resting MDA level was significantly lower (p<0.05} in the E trial compared 
to the P trial. At exhaustion, the MDA level was higher in the P trial (0.48 ± 0.04 vs 0.53 ± 
0.05 J.Jmol.l'1) but this was not statistically significant (p= 0.090). The plasma MDA level 
at 24 h post-exercise was significantly lower (p<0.05} than the corresponding value at 
exhaustion in the P trial. MDA levels at other time points were not significantly different 
between trials. After adjusting the data for plasma volume changes, all significant 
differences were maintained except the 24 h post-exercise value in the P trial. 
3.7 ENDURANCE RUNNING PERFORMANCE 
Running time to exhaustion was not significantly different between the E and p 
trials (81.1 ± 4.5 min vs. 76.9 ± 4.5 min respectively} (Fig. 3.5). 
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Figure 3.4 Plasma malondialdehyde (J.lmol.r1) during and after exercise in the 
vitamin E supplemented (E) and placebo (P) trials. 
* significantly different from P at p<0.05. 
••• significantly different from respective resting value (p<0.001 ). 
n significantly different from corresponding value at exhaustion (p<0.05). 
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Figure 3.5 Exercise time to exhaustion in the vitamin E supplemented (E) and 
placebo (P) trials. 
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3.8 FLUID INTAKE AND SWEAT RATE 
The volume of fluid ingested every 20 minutes and the total volume of fluid 
ingested was similar in both the trials (Table 3.3). Estimated sweat rate was also similar 
between trials (Table 3.3) 
3.9 BODY WEIGHT CHANGES 
Pre-exercise body weight, immediate post-exercise body weight, 24 h post-
exercise body weight and percentage of body weight loss were similar in both the trials 
(Table 3.3). 
Table 3.3 Pre, post and 24 h post-exercise body weight, percent body weight loss, 
volume of fluid ingested and estimated sweat loss during exercise in the vitamin E 
supplemented (E) and placebo (P) trials. 
Parameter Vitamin E Placebo 
(E) (P) 
Pre-exercise body weight 60.7 ± 1.5 60.5 ± 1.5 
(kg) 
Post-exercise body weight 59.5 ± 1.5+++ 59.3 ± 1.5+++ 
(kg) 
Body weight loss 1.9 ± 0.1 1.9 ± 0.1 
(Dfo) 
24-hr post-exercise body weight (kg) 60.2 + 1.5+++ 60.0 + 1.5++ 
Volume of fluid ingested 182.3 ± 4.6 181.9 ± 4.5 
(ml.20 min-1) 
Total volume of fluid ingested 751 ±54 697 ± 44 
(ml) 
Estimated sweat rate 1.39 ± 0.08 1.39 ± 0.06 (l.h-1) 
Values are means ± SE 
++,+++significantly different from respective pre-exercise body weight (p<0.01 and 
p<0.001, respectively). 
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